Activation of STAT6 in Intestinal Epithelial Cells Predisposes to Gut Inflammation
European Journal of Immunology · 2025
DOI: 10.1002/eji.202451394 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Immunology, 2025. Verfasst von Stefanie Westermann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infection Biology, University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany. Hauptthemen laut MEDLINE: STAT6 Transcription Factor, Intestinal Mucosa, Colitis, Ulcerative, Epithelial Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) often associated with a Type 2 immune response. Although previous reports hint at a role for signal transducer and activator of transcription (STAT) 6 signaling in non‐immune cells, the contribution of STAT6‐activation particularly in intestinal epithelial cells (IECs) is still unknown. Dextran sodium sulfate (DSS)‐induced colitis is a model for UC in mice that we applied here on animals with expression of a constitutively active version of STAT6 in IECs (VillinCre_STAT6vt mice). We report increased pathology and mortality due to enhanced and systemic inflammation in these mice. Bulk RNA sequencing of colonic tissue from naïve VillinCre_STAT6vt mice showed differential expression of more than 140 genes compared to control mice. Gene set enrichment analysis revealed STAT6‐regulated expression of the unfolded protein response, MTORC‐ and MYC‐signaling, and protein secretion pathways. A comparison of gene expression in the colon of naïve VillinCre_STAT6vt mice and a human single‐cell RNA sequencing dataset of a patient cohort with IBD revealed overlapping changes in the epithelial and macrophage compartment compared to corresponding controls. In conclusion, we found that activation of STAT6 in the intestinal epithelium predisposes to exacerbated colitis and gut inflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infection Biology, University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
- Department of Medicine 1, University Hospital Erlangen and Friedrich-Alexander University Erlangen-Nuremberg (FAU), Erlangen, Germany.
ORCID-Profile: Stefanie Westermann, Daniel Radtke, David Voehringer
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Westermann, S., Radtke, D., Kramer, L., Wirtz, S., & Voehringer, D. (2025). Activation of STAT6 in Intestinal Epithelial Cells Predisposes to Gut Inflammation. European Journal of Immunology. https://doi.org/10.1002/eji.202451394
Vancouver
Westermann S, Radtke D, Kramer L, Wirtz S, Voehringer D. Activation of STAT6 in Intestinal Epithelial Cells Predisposes to Gut Inflammation. European Journal of Immunology. 2025. doi:10.1002/eji.202451394
BibTeX
@article{Westermann2025,
author = {Westermann, Stefanie and Radtke, Daniel and Kramer, Lisa and Wirtz, Stefan and Voehringer, David},
title = {Activation of STAT6 in Intestinal Epithelial Cells Predisposes to Gut Inflammation},
journal = {European Journal of Immunology},
year = {2025},
doi = {10.1002/eji.202451394}
}
EUVIMED